Multidimensional minimal clinically important differences in knee osteoarthritis after comprehensive rehabilitation: a prospective evaluation from the Bad Zurzach Osteoarthritis Study

被引:46
作者
Angst, Felix [1 ]
Benz, Thomas [1 ]
Lehmann, Susanne [1 ]
Aeschlimann, Andre [1 ]
Angst, Jules [2 ]
机构
[1] Rehabil Clin RehaClin, Res Dept, Bad Zurzach, Switzerland
[2] Univ Zurich, Dept Psychiat Psychotherapy & Psychosomat, Psychiat Hosp Burgholzli, Zurich, Switzerland
来源
RMD OPEN | 2018年 / 4卷 / 02期
关键词
INPATIENT REHABILITATION; WESTERN ONTARIO; HEALTH-STATUS; WOMAC; RESPONSIVENESS; INDEX; SF-36; HIP; INSTRUMENTS; SIZES;
D O I
10.1136/rmdopen-2018-000685
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To determine minimal clinically important differences (MCIDs) for improvement and worsening in various health dimensions in knee osteoarthritis under conservative therapy. Methods Health, symptoms and function were assessed by the generic Short Form 36 and the condition-specific Western Ontario and McMaster Universities Osteoarthritis Index in n=190 patients with knee osteoarthritis before and after comprehensive rehabilitation intervention (3-month follow-up). By means of construct-specific transition questions, MCIDs were defined as the difference between the 'slightly better/worse' and the 'almost equal' transition response categories according to the 'mean change method'. The bivariate MCIDs were adjusted for sex, age and baseline score to obtain adjusted MCIDs by multivariate linear regression. They were further standardised as (baseline) effect sizes (ESs), standardised response means (SRMs) and standardised mean differences (SMDs) and compared with the minimal detectable change with 95% confidence (MDC95). Results Multivariate, adjusted MCIDs for improvement ranged from 2.89 to 16.24 score points (scale 0-100), corresponding to ES=0.14 to 0.63, SRM=0.17 to 0.61 and SMD=0.18 to 0.72. The matching results for worsening were -5.80 to -12.68 score points, ES=-0.30 to -0.56, SRM=-0.35 to -0.52 and SMD=-0.35 to -0.58. Almost all MCIDs were larger than the corresponding MDC95s. Conclusions This study presents MCIDs quantified according to different methods over a comprehensive range of health dimensions. In most health dimensions, multivariate adjustment led to higher symmetry between the MCID levels of improvement and worsening. MCIDs expressed as standardised effect sizes (ES, SRM, SMD) and adjusted by potential confounders facilitate generalisation to the results of other studies.
引用
收藏
页数:9
相关论文
共 32 条
  • [11] Bellamy N., 1995, WOMAC OSTEOARTHRITIS
  • [12] Development of Multinational Definitions of Minimal Clinically Important Improvement and Patient Acceptable Symptomatic State in Osteoarthritis
    Bellamy, Nicholas
    Hochberg, Marc
    Tubach, Florence
    Martin-Mola, Emilio
    Awada, Hassane
    Bombardier, Claire
    Hajjaj-Hassouni, Najia
    Logeart, Isabelle
    Matucci-Cerinic, Marco
    van de Laar, Mart
    van der Heijde, Desiree
    Dougados, Maxime
    [J]. ARTHRITIS CARE & RESEARCH, 2015, 67 (07) : 972 - 980
  • [13] Bullinger M., 1998, SF-36 Fragebogen zum Gesundheitszustand - HandanweisungAufl
  • [14] Davey RC., 2003, Adv Physiother, V5, P155, DOI DOI 10.1080/1403819038190310017075
  • [15] Three ways to quantify uncertainty in individually applied "minimally important change" values
    de Vet, Henrica C. W.
    Terluin, Berend
    Knol, Dirk L.
    Roorda, Leo D.
    Mokkink, Lidwine B.
    Ostelo, Raymond W. J. G.
    Hendriks, Erik J. M.
    Bouter, Lex M.
    Terwee, Caroline B.
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2010, 63 (01) : 37 - 45
  • [16] Responsiveness and clinically important differences for the WOMAC and SF-36 after total knee replacement
    Escobar, A.
    Quintana, J. M.
    Bilbao, A.
    Arosteigui, I.
    Lafuente, I.
    Vidaurreta, I.
    [J]. OSTEOARTHRITIS AND CARTILAGE, 2007, 15 (03) : 273 - 280
  • [17] Clinically important improvement in the WOMAC and predictor factors for response to non-specific non-steroidal anti-inflammatory drugs in osteoarthritic patients: A prospective study
    Hmamouchi I.
    Allali F.
    Tahiri L.
    Khazzani H.
    Mansouri L.
    Ali Ou Alla S.
    Abouqal R.
    Hajjaj-Hassouni N.
    [J]. BMC Research Notes, 5 (1)
  • [18] MEASUREMENT OF HEALTH-STATUS - ASCERTAINING THE MINIMAL CLINICALLY IMPORTANT DIFFERENCE
    JAESCHKE, R
    SINGER, J
    GUYATT, GH
    [J]. CONTROLLED CLINICAL TRIALS, 1989, 10 (04): : 407 - 415
  • [19] Kamath CCSJ, 2014, BALAKRISHNANMETHODS, P170, DOI DOI 10.1002/9781118596005.CH15
  • [20] Introduction to Special Issue: Patient Outcomes in Rheumatology, 2011
    Katz, Patricia P.
    [J]. ARTHRITIS CARE & RESEARCH, 2011, 63 : S1 - S3